A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients.
Phase of Trial: Phase IV
Latest Information Update: 08 Nov 2016
At a glance
- Drugs Choline alfoscerate (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 01 Nov 2016 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.
- 11 Jan 2016 New trial record